Eye drops characterized by containing a quinazoline derivative represented by formula (I) (wherein A and B each represents lower alkylene and X, Y, and Z each represents halogeno) or a pharmacologically acceptable salt thereof in an amount of 0.001 to 10.0 W/V%.
